Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

Clinical trial NCT05644210 · UNKNOWN

Trial details

NCT number: NCT05644210
Sponsor: Qilu Hospital of Shandong University
Status: UNKNOWN
Study type: OBSERVATIONAL

Antiphospholipid Syndrome

Start date: 2022-10-01
Primary completion: 2025-12-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.